India, Aug. 7 -- The Maharashtra Food and Drug Administration (FDA) has permanently cancelled the manufacturing licence of Inducare Pharma Pvt Ltd, an Ayurvedic drug manufacturer based in Jejuri MIDC in Pune district, after inspections found violations of Good Manufacturing Practices (GMP) and quality standards, officials said on Thursday.

The action followed violations of the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and GMP norms found in two inspections.

According to FDA, six medicines manufactured by the company were declared "Not of Standard Quality" (NSQ) by the government analyst based on laboratory test reports. These included Sinhanad Guggul, Punarnavadi Mandur, Triphala Guggul, Kanchanar Guggul, Hingv...